Speaker illustration

Doctor Arancha Diaz Exposito

Virgin of Victory University Hospital, Malaga (Spain)

Member of:

Heart Failure Association

Prevalence of ICD therapies in primary prevention vs secondary prevention in a sample of patients diagnosed with arrhythmogenic cardiomyopathy

Event: Heart Failure 2025

Topic: Implantable Cardioverter-Defibrillator (ICD)

Session: Cardiovascular implantable electronic device in patients with heart failure

Thumbnail

A new phenotypic presentation of the p.Gly1743Arg variant in SCN5A classically associated with Brugada syndrome.

Event: Heart Failure 2025

Topic: Clinical

Session: It’s all about genetics

Thumbnail

Phenotypic manifestation based on genetics and prevalence of secondary mutations in a sample of patients diagnosed with arrhythmogenic cardiomyopathy

Event: Heart Failure 2025

Topic: Dilated Cardiomyopathy

Session: Markers in and of dilated cardiomyopathy

Thumbnail

What the heart hides. Necrotising myopathy due to SRP antibodies with associated cardiac involvement in the context of mucinous adenocarcinoma of the lung.

Event: Heart Failure 2024

Topic: Clinical

Session: Cardiomyopathies - stress and the heart

Thumbnail

ICD implantation in primary prevention. Beyond left ventricular ejection fraction.

Event: Heart Failure 2024

Topic: Implantable Cardioverter-Defibrillator (ICD)

Session: Cardiomyopathies - arrhythmias

Thumbnail

Incidence and progression of left ventricular involvement in patients with arrythmogenic cardiomyopathy

Event: Heart Failure 2024

Topic: Clinical

Session: ePosters in myocardial disease 1

Thumbnail

Hypertrophic cardiomyopathy and pulmonary hypertension. A lethal combination

Event: Heart Failure 2023

Topic: Myocardial Disease

Session: Myocardial disease 3

Thumbnail

New clues to the diagnosis of dynamic obstructive gradiente in hypertrophic cardiomyopathy. The power of ergoespirometry

Event: Heart Failure 2023

Topic: Myocardial Disease

Session: Myocardial disease 2

Thumbnail

A new possibly pathogenic mutation in the ACTA 1 gene. Beyond skeletal muscle involvement

Event: Heart Failure 2023

Topic: Myocardial Disease

Session: Myocardial disease 1

Thumbnail

Evolution of patients with advanced heart failure with ambulatory intermitent infusions of long-term Levosimendan

Event: Heart Failure 2023

Topic: Pharmacotherapy

Session: ePosters in chronic heart failure - pharmacotherapy 4

Thumbnail